INSTITUTE OF MATERIA MEDICA; CHINESE ACADEMY OF MEDICAL SCIENCES
发明人:
申请号：
EP17886474.0
公开号：
EP3560921A1
申请日:
2017.12.26
申请国别(地区):
EP
年份:
2019
代理人:
摘要：
The invention relates to quinazoline compounds, the preparation method, use, and the pharmaceutical composition thereof. The said quinazoline compounds, which are represented by Formula (I), are phosphatidylinositol 3-kinase (PI3K) inhibitors, and can be applied to prevent and/or treat PI3K activity-related diseases, such as cancer, immune diseases, cardiovascular diseases, viral infections, inflammation, metabolism/endocrine function disorders or neurological diseases.
